Literature DB >> 27605890

Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.

Cláudio Martins1, Cristina Teixeira1, Suzane Ribeiro1, Daniel Trabulo1, Cláudia Cardoso1, João Mangualde1, Ricardo Freire1, Élia Gamito1, Ana Luísa Alves1, Isabelle Cremers1, Cecília Alves1, Anabela Neves1, Ana Paula Oliveira1.   

Abstract

Mastocytosis is a clonal neoplastic disorder of the mast cells (MC) that can be limited to the skin (cutaneous mastocytosis) or involve one or more extracutaneous organs (systemic mastocytosis). The clinical manifestations of mastocytosis are heterogeneous ranging from indolent disease with a long-term survival to a highly aggressive neoplasm with survival of about 6 mo. Although liver involvement in aggressive systemic mastocytosis (ASM) is relatively common, the development of portal hypertension with or without cirrhosis is rare. We report a case of ASM without skin involvement in a 72-year-old caucasian male who presented with non-cirrhotic portal hypertension based on clinical, analytical, imagiological and endoscopic findings. Given the hematological picture, the correct diagnosis was established based on ancillary tests for MC using bone marrow aspirates and biopsy. Extensive involvement of the liver and gastrointestinal tract was histologically documented. The disease progressed rapidly and severe pancytopenia and recurrent upper gastrointestinal bleeding became the dominant problem. This case illustrates the challenge in establishing a diagnosis of ASM especially when the clinical picture is atypical and without skin involvement. Gastroenterologists should consider infiltrative disease, particularly systemic mastocytosis, as a differential diagnosis in a clinical case of portal hypertension of unknown etiology.

Entities:  

Keywords:  Cladribine; Mast cells; Non-cirrhotic portal hypertension; Systemic mastocytosis; Upper gastrointestinal bleeding

Mesh:

Year:  2016        PMID: 27605890      PMCID: PMC4968135          DOI: 10.3748/wjg.v22.i28.6559

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients.

Authors:  Philippe Casassus; Nadine Caillat-Vigneron; Antoine Martin; Jeanne Simon; Valérie Gallais; Patrice Beaudry; Virginie Eclache; Liliane Laroche; Pierre Lortholary; Martine Raphaël; Loïc Guillevin; Olivier Lortholary
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

Review 2.  Systemic mastocytosis.

Authors:  Cem Akin; Dean D Metcalfe
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

3.  Teaching cases from the Royal Marsden and St Mary's Hospitals: Case 27, ascites and oedema in a patient with systemic mastocytosis.

Authors:  Jo Addada; Jo Lloyd; Barbara Bain
Journal:  Leuk Lymphoma       Date:  2004-08

4.  Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.

Authors:  Ken H Lim; Animesh Pardanani; Joseph H Butterfield; Chin-Yang Li; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

Review 5.  Gastrointestinal abnormalities and involvement in systemic mastocytosis.

Authors:  R T Jensen
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

Review 6.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

7.  Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders.

Authors:  H P Horny; M Ruck; M Wehrmann; E Kaiserling
Journal:  Br J Haematol       Date:  1990-10       Impact factor: 6.998

Review 8.  Systemic mastocytosis: a concise clinical and laboratory review.

Authors:  Mrinal M Patnaik; Michelle Rindos; Peter A Kouides; Ayalew Tefferi; Animesh Pardanani
Journal:  Arch Pathol Lab Med       Date:  2007-05       Impact factor: 5.534

9.  Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.

Authors:  J B Lawrence; B S Friedman; W D Travis; V M Chinchilli; D D Metcalfe; H R Gralnick
Journal:  Am J Med       Date:  1991-12       Impact factor: 4.965

10.  Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases.

Authors:  Richard Kirsch; Karel Geboes; Neil A Shepherd; Gert de Hertogh; Nando Di Nicola; Sylvie Lebel; Ugnius Mickys; Robert H Riddell
Journal:  Mod Pathol       Date:  2008-10-17       Impact factor: 7.842

View more
  2 in total

1.  A Granular Approach to a Patient with Diarrhea and Flushing.

Authors:  Anas Gremida; Fazia Mir; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

2.  Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension.

Authors:  Hongjuan Yao; Yongliang Wang
Journal:  Open Life Sci       Date:  2020-12-31       Impact factor: 0.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.